MedPath

Meeting Protein Targets in Critically Ill Patients

Completed
Conditions
Critical Illness
Dietary Modification
Registration Number
NCT03319836
Lead Sponsor
Société des Produits Nestlé (SPN)
Brief Summary

This is a retrospective study of protein and energy intake in enterally fed critically ill adult patients before and after the introduction of a very high protein enteral nutrition formula in a single center medical/surgical ICU.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
40
Inclusion Criteria
  • Adult patients ≥ 18 years of age, mechanically ventilated
  • Received enteral nutrition for a minimum of five days during the first week of ICU admission
Exclusion Criteria
  • Received parenteral nutrition during first week of ICU admission
  • Acute renal failure not dialyzed
  • Hepatic encephalopathy grade 3 or 4
  • Intentional underfeeding/trophic feeding - including refeeding syndrome

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Daily total protein intakeDaily up to 7 days of ICU stay

Daily total protein intake and percent prescribed protein needs met during first week of ICU admission.

Secondary Outcome Measures
NameTimeMethod
Daily caloric intake - Total CaloriesDaily up to 7 days of ICU stay

Total calories aggregate from all sources

Daily caloric intake from enteral nutritionDaily up to 7 days of ICU stay

Daily caloric intake from enteral nutrition, and medications (i.e. Propofol)

Daily caloric intake - kcal/kgDaily up to 7 days of ICU stay

Total volume consumed and weight will be used to measure kcal/kg

Percentage of prescribed calorie needs metDaily up to 7 days of ICU stay

Percentage of prescribed calorie needs met

Feeding interruptionsDaily up to 7 days of ICU stay

Feeding interruptions; and reason for interruption, if recorded in electronic medical record/nursing flow sheets

Use of inotropes/vasopressors (highest daily dose prescribed)Daily up to 7 days of ICU stay

Use of inotropes/vasopressors will be documented as a Yes/No.

Feeding toleranceDaily up to 7 days of ICU stay

Feeding tolerance as recorded by clinicians in electronic medical record/nursing flow sheets \[gastrointestinal side effects observed and documented: vomiting, elevated Gastric Residual Volumes (\>200 mL), aspiration, pneumonia, diarrhea (Bristol stool chart definition and ≥ 3 liquid stools/day)\]

Trial Locations

Locations (1)

Hamilton Health Sciences

🇨🇦

Hamilton, Ontario, Canada

© Copyright 2025. All Rights Reserved by MedPath